NCT06330103

Brief Summary

Assessing the Efficacy of Artificial Intelligence in Left Ventricular Function Screening Using Parasternal Long Axis View Cardiac Ultrasound Video Clips ABSTRACT BACKGROUND: Echocardiography serves as a fundamental diagnostic procedure for managing heart failure patients. Data from Thailand's Ministry of Public Health reveals that there is a substantial patient population, with over 100,000 admissions annually due to this condition. Nevertheless, the widespread implementation of echocardiography in this patient group remains challenging, primarily due to limitations in specialist resources, particularly in rural community hospitals. Although modern community hospitals are equipped with ultrasound machines capable of basic cardiac assessment (e.g., parasternal long axis view), the demand for expert cardiologists remains a formidable obstacle to achieving comprehensive diagnostic capabilities. Leveraging the capabilities of Artificial Intelligence (AI) technology, proficient in the accurate prediction and processing of diverse healthcare data types, offers a promising for addressing this prevailing issue. This study is designed to assess the effectiveness of AI in evaluating cardiac performance from parasternal long axis view ultrasound video clips obtained via the smartphone application. OBJECTIVES: To evaluate the effectiveness of artificial intelligence in screening cardiac function from parasternal long axis view cardiac ultrasound video clips obtained through the smartphone application.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
923

participants targeted

Target at P75+ for not_applicable heart-failure

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

March 5, 2024

Last Update Submit

March 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • efficiency of AI in screening left ventricular cardiac function by use smartphone application

    percentage of correct LV function clip that interpreted by AI in each LV function group(Preserved LV, Mildly reduced LV, Reduced LV function) and overall compare with result from certified cardiologist

    3 month

Study Arms (2)

LV function from cardiologist

ACTIVE COMPARATOR

Certified Cardiologist will access and interpreted LV function by used traditional Echocardiography then separate result into three group Preserved LV ejection fraction(EF\>50%), mildly reduce ejection fraction(EF40-49%), reduced LV ejection fraction(EF\<40%)

Other: Easy EF

LV function By artificial intelligence

EXPERIMENTAL

AI will access VDO clips in only parasternal long axis view and separate into three group Preserved LV ejection fraction(EF\>50%), mildly reduce ejection fraction(EF40-49%), reduced LV ejection fraction(EF\<40%)

Other: Easy EF

Interventions

Easy EFOTHER

AI was integrated into the application smartphone and used smartphone camera to recorded shot VDO clip of heart ultrasound in parasternal long axis view and returned cardiac function result to user.

Also known as: artificial intelligence, mobile smart phone application
LV function By artificial intelligenceLV function from cardiologist

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Shot 5 second VDO clip of Parasternal long axis heart ultrasound recorded by smartphone Application "Easy EF" without patient identification with result of Ejection fraction that performed by certify cardiologist approved result

You may not qualify if:

  • Incomplete VDO clip (too much shaking, too shot recording)
  • Lighting was inappropriate
  • Inappropriate ultrasound framing
  • arrhythmia (atrial fibrillation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rayong Hospital

Rayong, 066, Thailand

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Artificial Intelligence

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

AlgorithmsMathematical Concepts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: 923 samples that were evaluated for LVEF by certified cardiologists, 739 clips were used to train AI, while the remaining 184 clips were used to test if AI could process the results correctly. Artificial intelligence aims to classify cardiac function into three groups: Reduced EF, Mildly Reduced EF, and Preserved LV.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 5, 2024

First Posted

March 26, 2024

Study Start

May 1, 2023

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

March 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

result of AI screening

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
3 month
Access Criteria
contact rayong hospital

Locations